VR for Cataract Anxiety Lowering Management
VR-CALM
A Non-Randomized Controlled Trial of Virtual Reality Simulation of Intraoperative Audiovisual Experience to Reduce Anxiety in Cataract Surgery Patients
2 other identifiers
interventional
60
0 countries
N/A
Brief Summary
Cataract is currently the leading cause of blindness globally, and surgery is the only effective treatment. With the advancement of medical technology, cataract surgery is usually performed under topical anesthesia, which means patients will be awake during the procedure, able to see the light from the surgical lamp and hear the sounds of surgical instruments being operated. Some patients may feel nervous or scared due to unfamiliarity with the surgical process, which may lead to increased blood pressure, rapid heartbeat, and even affect their cooperation during the surgery. Virtual reality (VR) technology is a new multimedia technology. By wearing VR glasses, patients can immerse themselves in a virtual world and see and hear realistic scenes. Through this study, the investigators aim to investigate whether allowing cataract patients to "experience" a surgical procedure in advance through VR glasses before cataract surgery can help alleviate their nervousness during the actual surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2026
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2026
CompletedFirst Submitted
Initial submission to the registry
May 6, 2026
CompletedFirst Posted
Study publicly available on registry
May 14, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 30, 2026
May 14, 2026
May 1, 2026
4 months
May 6, 2026
May 12, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
Intraoperative anxiety numerical rating scale (NRS)
Intraoperative participants self-reported anxiety level using numerical rating scale (NRS), from 0 (no anxiety) to 10 (highest anxiety)
collected immediately after the surgery
Secondary Outcomes (4)
HR
collected during the surgery
BP
collected during the surgery
Pain Numerical Rating Scale (NRS)
collected immediately after the surgery
Cooperation Numerical Rating Scale (NRS)
collected immediately after the surgery
Study Arms (2)
VR Intervention Group
EXPERIMENTAL30 participants receive VR simulation of intraoperative audiovisual experience before the surgery.
Usual Care Group (No VR)
NO INTERVENTIONParticipants with conventional preoperative instructions (no VR)
Interventions
This Virtual reality video simulates the audiovisual experience of phacoemulsification (Phaco and IOL) surgery
Eligibility Criteria
You may qualify if:
- Diagnosed with cataracts in both eyes, and planning to undergo surgical treatment
- Voluntarily participate in this trial and sign the informed consent form.
You may not qualify if:
- Having any history of previous ophthalmic surgery.
- Suffering from severe hearing impairment, unable to comprehend VR video content.
- Those who suffer from cognitive dysfunction or mental illness and are unable to cooperate in completing the scale assessment.
- Suffering from severe macular diseases, glaucoma, or other ocular diseases that may affect surgery or interfere with the assessment of tension level.
- Assessed as intolerant to surface anesthesia surgery.
- History of motion sickness, severe vertigo, or intolerance to VR video viewing (such as claustrophobia).
- Other situations where the researcher deems the participant unsuitable for participation in this study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
May 6, 2026
First Posted
May 14, 2026
Study Start
May 1, 2026
Primary Completion (Estimated)
August 30, 2026
Study Completion (Estimated)
September 30, 2026
Last Updated
May 14, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share